MeSH D009165 - nontuberculous mycobacterium infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Azithromycin | Azithromycin |  | 2005-11-14 |  |  |
| Clarithromycin | Clarithromycin |  | 2005-05-31 |  |  | |
| Taro Pharmaceutical | Azithromycin | Azithromycin |  | 2019-12-11 |  |  |
| Mylan | Azithromycin | Azithromycin |  | 2007-05-30 |  |  |
| Clarithromycin | Clarithromycin |  | 2005-03-11 |  |  | |
| Lupin Research | Azithromycin | Azithromycin |  | 2015-05-15 |  |  |
| Clarithromycin | Clarithromycin |  | 2015-09-15 |  |  | |
| Ethambutol | Ethambutol |  | 2009-06-17 |  |  | |
| Sandoz | Azithromycin | Azithromycin |  | 2005-11-14 |  |  |
| Clarithromycin | Clarithromycin |  | 2005-08-25 |  |  | |
| Amoxicillin, Lansoprazole, Clarithromycin | Lansoprazole, Amoxicillin Clarithromycin |  | 2014-03-04 |  |  | |
| AbbVie | Clarithromycin | Biaxin |  | 1991-10-31 |  |  |
| Pfizer | Azithromycin, Trovafloxacin | Trovan/zithromax Compliance |  | 1998-12-18 |  |  |
| Azithromycin | Zithromax |  | 1991-11-01 | $406 M | Y2023 | |
| Takeda | Amoxicillin, Lansoprazole, Clarithromycin | Prevpac |  | 1997-12-02 |  |  |
| Aurobindo Pharma | Azithromycin | Azithromycin |  | 2007-01-08 |  |  |
| Clarithromycin | Clarithromycin |  | 2012-07-25 |  |  | |
| Barr Pharmaceuticals | Ethambutol | Ethambutol |  | 2001-11-26 |  |  |
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
50%1/2
Phase 2
36%4/11
Phase 3
75%6/8
Approved: 3Overall Success rate: 14%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use